1. Final results from a phase II trial of ZD1839 (‘Iressa’) for patients with advanced non-small cell lung cancer (IDEAL 1);Fukuoka;Proc Am Soc Clin Oncol,2002
2. A phase II trial of ZD1839 (‘Iressa’) in advanced non-small cell lung cancer (NSCLC) patients who had failed platinum- and docetaxel-based regimens (IDEAL 2);Kris;Proc Am Soc Clin Oncol,2002
3. Epidermal growth factor system regulates mucin production in airways;Takeyama;Proc Natl Acad Sci USA,1999
4. A Phase III clinical trial of ZD1839 (‘Iressa’) in combination with gemcitabine and cisplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer (INTACT 1);Giaccone;Ann Oncol,2002